Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist

BACKGROUND: Venous thromboembolism (VTE) is a burden on healthcare systems. Standard treatment involves parenteral anticoagulation overlapping with a vitamin K antagonist, an approach that is effective but associated with limitations including the need for frequent coagulation monitoring. The direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Bamber, Luke, Muston, Dominic, McLeod, Euan, Guillermin, Anne, Lowin, Julia, Patel, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464718/
https://www.ncbi.nlm.nih.gov/pubmed/26074735
http://dx.doi.org/10.1186/s12959-015-0051-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464718/
https://www.ncbi.nlm.nih.gov/pubmed/26074735
http://dx.doi.org/10.1186/s12959-015-0051-3

Ejemplares similares